Welcome to Scribd, the world's digital library. Read, publish, and share books and documents. See more
Download
Standard view
Full view
of .
Save to My Library
Look up keyword or section
Like this
9Activity
P. 1
Sapm Final

Sapm Final

Ratings: (0)|Views: 3,325|Likes:
Published by parinchawda
Analysis of pharma industry
Analysis of pharma industry

More info:

Published by: parinchawda on Sep 25, 2009
Copyright:Attribution Non-commercial

Availability:

Read on Scribd mobile: iPhone, iPad and Android.
download as PDF, TXT or read online from Scribd
See more
See less

05/21/2013

pdf

text

original

 
 
Security Analysis AndPortfolio Management Report 
On
 Pharmaceutical Industry
Submitted By:
Kailas Dalvi (RollNo. 21)Parin Chawda( RollNo. 33)Shashan Singh Rathore(RollNo. 44)MBA(IB)2008-10IIFT Kolkata
 
 
2
Table of Contents
ECONOMIC ANALYSIS .............................................................................................................................. 4INDIAN PERSPECTIVE .......................................................................................................................... 4OUTPUT ............................................................................................................................................... 4AGRICULTURE ..................................................................................................................................... 6INDUSTRIAL ......................................................................................................................................... 6INFRASTRUCTURE ............................................................................................................................... 7SERVICES ............................................................................................................................................. 7AGGREGATE DEMAND ........................................................................................................................ 8MONETARY CONDITIONS .................................................................................................................... 9INFLATION ......................................................................................................................................... 10MACROECONOMIC OUTLOOK .......................................................................................................... 11INDUSTRY ANALYSIS .............................................................................................................................. 12GLOBAL INDUSTRY ............................................................................................................................ 13INDIAN PHARMAEUTICAL INDUSTRY ................................................................................................ 14PHARMACEUTICAL INDUTRY STRUCTURE .................................................................................... 16SWOT ANALYSIS ............................................................................................................................ 16GROWTH DRIVERS ........................................................................................................................ 18
.................................................................................................... 22COMPANY ANALYSIS ............................................................................................................................. 23CIPLA LTD .......................................................................................................................................... 23SHAREHOLDING PATTERN ............................................................................................................. 23INVESTMENT STRATEGY ................................................................................................................ 23KEY RISKS ....................................................................................................................................... 24ECONOMIC ACTIVITIES .................................................................................................................. 24RECENT DEVELOPMENTS .............................................................................................................. 24FINANCIAL ANALYSIS ..................................................................................................................... 25SWOT ANALYSIS ............................................................................................................................ 26GLENMARK PHARMACEUTICALS ...................................................................................................... 27SHAREHOLDING PATTERN ............................................................................................................. 27INVESTMENT RATIONALE:............................................................................................................. 27KEY RISKS ....................................................................................................................................... 28
 
3ECONOMIC ACTIVITIES .................................................................................................................. 28RECENT DEVELOPMENTS .............................................................................................................. 28FINANCIAL ANALYSIS ..................................................................................................................... 29SWOT ANALYSIS ............................................................................................................................ 30GLAXO SMITHKLINE PHARMA ........................................................................................................... 31SHAREHOLDING PATTERN ............................................................................................................. 31INVESTMENT RATIONALE .............................................................................................................. 31KEY RISKS ....................................................................................................................................... 32ECONOMIC ACTIVITIES .................................................................................................................. 32RECENT DEVELOPMENTS .............................................................................................................. 32FINANCIAL ANALYSIS ..................................................................................................................... 33SWOT ANALYSIS ............................................................................................................................ 35REFERENCES .......................................................................................................................................... 36APPENDIX .............................................................................................................................................. 37CIPLA LTD .......................................................................................................................................... 37ESTIMATED B/L SHEET .................................................................................................................. 37PRICE ESTIMATION ........................................................................................................................ 38GLENMARK PHARMACEUTICALS ....................................................................................................... 40ESTIMATED B/L SHEET .................................................................................................................. 40PRICE ESTIMATION ........................................................................................................................ 41GLAXO SMITHKLINE PHARMA ........................................................................................................... 43ESTIMATED B/L SHEET .................................................................................................................. 43PRICE ESTIMATION ........................................................................................................................ 44

Activity (9)

You've already reviewed this. Edit your review.
1 hundred reads
1 thousand reads
fkkfox liked this
Anuj Talati liked this
Harsh M Shah liked this
Shefali Patel liked this
Asma Shaikh liked this
prafulshettigar liked this
timoleon liked this

You're Reading a Free Preview

Download
/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->